CME Group CME
$305.89 −$1.35 (-0.44%)
Market closed · Nov 6, 9:50 pm ET · Last extended-hours $305.89 0.00%
Open$303.68
Prev close$307.24
Day range$301.40 – $308.76
Volume1.45M
Market cap$109.49B
P/E (TTM)25.1
Dividend yield3.69%
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.74B+13.0% YoY
Operating profit$1.14B+17.4% YoY
Net profit$1.04B+14.2% YoY
Diluted EPS$2.89+16.1% YoY
Free cash flow$1.07B+12.7% YoY
Operating cash flow$1.09B
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin86.6%
Operating margin65.7%
Net margin63.1%
Return on equity16.1%
Return on assets2.3%
Return on invested capital14.7%
Current ratio1.02
Liabilities / assets86.2%
Cash & investments$2.33B
Total debt$3.43B
Net cash (debt)-$1.10B
Free cash flow / sales62.1%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.74B | $1.71B | $1.88B | $6.52B | $1.65B |
| Total Operating Revenue | $1.74B | $1.71B | $1.88B | $6.52B | $1.65B |
| Cost of Revenue | $234.30M | $233.50M | $223.00M | $907.00M | $241.10M |
| Gross Profit | $1.50B | $1.47B | $1.66B | $5.61B | $1.41B |
| Operating Expense | $361.60M | $365.60M | $347.40M | $1.38B | $388.00M |
| Selling and Admin Expenses | $31.10M | $29.10M | $28.20M | $150.50M | $47.90M |
| -General & Admin Expense | $31.10M | $29.10M | $28.20M | $150.50M | $47.90M |
| Depreciation & Amortization & Depletion | $83.40M | $84.20M | $83.30M | $330.90M | $82.40M |
| -Depreciation & Amortization | $83.40M | $84.20M | $83.30M | $330.90M | $82.40M |
| Other Operating Expenses | $247.10M | $252.30M | $235.90M | $902.70M | $257.70M |
| Operating Profit | $1.14B | $1.11B | $1.31B | $4.23B | $1.02B |
| Net Non-Operating Interest Income (Expense) | -$43.50M | -$43.60M | -$43.60M | -$173.40M | -$43.70M |
| Non-Operating Interest Expense | $43.50M | $43.60M | $43.60M | $173.40M | $43.70M |
| Other Income (Expense) | $256.90M | $264.20M | $244.80M | $1.27B | $602.50M |
| Gain on Sale of Security | $1.42B | $1.43B | $1.39B | $5.74B | $1.78B |
| Earnings from Equity Interest | $102.80M | $97.70M | $102.40M | $371.70M | $88.20M |
| Other Non-Operating Income (Expenses) | -$1.26B | -$1.26B | -$1.25B | -$4.83B | -$1.26B |
| Pretax Profit | $1.35B | $1.33B | $1.51B | $5.33B | $1.58B |
| Tax | $317.90M | $285.90M | $356.60M | $1.26B | $395.50M |
| Net Profit | $1.04B | $1.04B | $1.15B | $4.07B | $1.18B |
| Profit from Continuing Operations | $1.04B | $1.04B | $1.15B | $4.07B | $1.18B |
| Net Income to Parent Company | $1.04B | $1.04B | $1.15B | $4.07B | $1.18B |
| Other Preferred Stock Dividends | $0.00 | $0.00 | -$13.70M | $28.30M | $9.20M |
| Net Income to Common Stockholders | $1.04B | $1.04B | $1.17B | $4.02B | $1.17B |
| Basic EPS | $2.90 | $2.89 | $3.25 | $11.18 | $3.25 |
| Diluted EPS | $2.89 | $2.88 | $3.18 | $11.16 | $3.24 |
| Dividend Per Share | $1.30 | $1.30 | $7.45 | $5.00 | $1.25 |
| Preferred Stock Dividends | – | – | -$13.70M | $22.90M | $5.70M |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $192.09B | $194.68B | $201.99B | $198.42B | $198.42B |
| Total Current Assets | $159.14B | $161.63B | $169.00B | $165.36B | $165.36B |
| Cash and Cash Equivalents & Short-Term Investments | $2.33B | $2.28B | $2.52B | $4.54B | $4.54B |
| -Cash and Cash Equivalents | $2.20B | $2.14B | $2.39B | $4.42B | $4.42B |
| -Short Term Investments | $131.00M | $131.40M | $124.20M | $125.00M | $125.00M |
| Receivables | $788.10M | $753.10M | $935.50M | $639.20M | $639.20M |
| -Accounts Receivable | $788.10M | $753.10M | $935.50M | $639.20M | $639.20M |
| Restricted Cash | $155.18B | $158.12B | $165.04B | $159.66B | $159.66B |
| Other Current Assets | $837.40M | $487.30M | $508.60M | $515.60M | $515.60M |
| Total Non-Current Assets | $32.95B | $33.05B | $32.99B | $33.06B | $33.06B |
| Net PPE | $338.70M | $351.20M | $355.40M | $362.70M | $362.70M |
| -Gross PPE | $1.36B | $1.34B | $1.38B | $1.37B | $1.37B |
| -Accumulated Depreciation | -$1.02B | -$993.70M | -$1.03B | -$1.01B | -$1.01B |
| Goodwill and Other Intangible Assets | $30.12B | $30.18B | $30.23B | $30.30B | $30.30B |
| -Goodwill | $10.51B | $10.51B | $10.51B | $10.51B | $10.51B |
| -Other Intangible Assets | $19.62B | $19.67B | $19.73B | $19.79B | $19.79B |
| Other Non-Current Assets | $2.49B | $2.52B | $2.40B | $2.40B | $2.40B |
| Total Liabilities | $165.53B | $168.16B | $175.38B | $169.70B | $169.70B |
| Total Current Liabilities | $156.11B | $158.72B | $166.00B | $160.30B | $160.30B |
| Payables | $67.70M | $68.00M | $75.40M | $71.80M | $71.80M |
| -Accounts Payable | $67.70M | $68.00M | $75.40M | $71.80M | $71.80M |
| Other Current Liabilities | $156.05B | $158.65B | $165.92B | $160.22B | $160.22B |
| Total Non-Current Liabilities | $9.42B | $9.44B | $9.38B | $9.40B | $9.40B |
| Long Term Debt and Capital Lease Obligation | $3.43B | $3.42B | $3.42B | $3.42B | $3.42B |
| -Long Term Debt | $3.43B | $3.42B | $3.42B | $3.42B | $3.42B |
| Non-Current Deferred Liabilities | $5.21B | $5.22B | $5.22B | $5.24B | $5.24B |
| Other Non-Current Liabilities | $785.60M | $793.80M | $733.20M | $734.80M | $734.80M |
| Total Equity | $26.56B | $26.52B | $26.62B | $28.73B | $28.73B |
| Stockholders' Equity | $26.56B | $26.52B | $26.62B | $28.73B | $28.73B |
| Capital Stock | $3.60M | $3.60M | $3.60M | $3.60M | $3.60M |
| -Common Stock | $3.60M | $3.60M | $3.60M | $3.60M | $3.60M |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $20.47B | $21.00B | $21.67B | $22.21B | $22.21B |
| Retained Earnings | $6.03B | $5.46B | $4.88B | $6.43B | $6.43B |
| Gains/Losses Not Affecting Retained Earnings | $55.50M | $54.90M | $59.40M | $81.90M | $81.90M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.09B | $947.10M | $1.26B | $4.28B | $1.13B |
| Net cash flow from continuing operations | $1.09B | $947.10M | $1.26B | $4.28B | $1.13B |
| Net Income from Continuing Operations | $1.04B | $1.04B | $1.15B | $4.07B | $1.18B |
| Gain/Loss from Continuing Operations | $300,000.00 | -$3.80M | $22.90M | -$352.80M | -$349.80M |
| Depreciation & Depletion & Amortization | $83.40M | $84.20M | $83.30M | $330.90M | $82.40M |
| Deferred Tax | -$4.20M | $5.20M | -$13.40M | -$6.10M | $21.30M |
| Other Non-Cash Items | -$23.40M | -$5.80M | -$11.10M | $38.40M | $63.80M |
| Change in Working Capital | -$31.20M | -$199.30M | $2.10M | $99.70M | $104.40M |
| -Change in Receivables | -$35.10M | $182.90M | -$295.80M | -$67.10M | $2.80M |
| -Change in Payables and Accrued Expense | -$9.50M | -$375.40M | $331.20M | $83.00M | $60.40M |
| -Change in Other Current Assets | -$157.40M | -$57.50M | -$46.60M | $31.80M | -$27.70M |
| -Change in Other Current Liabilities | $170.80M | $50.70M | $13.30M | $52.00M | $68.90M |
| Net cash flow from investing | -$20.60M | -$29.40M | -$23.00M | $1.50B | $1.55B |
| Net Cash Flow from Continuing Investing Activities | -$20.60M | -$29.40M | -$23.00M | $1.50B | $1.55B |
| Net PPE Purchase and Sale | -$15.80M | -$23.60M | -$21.80M | -$83.50M | -$32.50M |
| Net Business Purchase and Sale | -$4.90M | -$5.30M | -$1.50M | $1.58B | $1.58B |
| Net Investment Purchase and Sale | $100,000.00 | -$500,000.00 | $300,000.00 | $1.90M | $600,000.00 |
| Financing Cash Flow | -$3.94B | -$8.09B | $2.12B | $56.51B | $9.90B |
| Net Cash Flow from Continuing Financing Activities | -$3.94B | -$8.09B | $2.12B | $56.51B | $9.90B |
| Net Issuance Payments Of Debt | $0.00 | $0.00 | $0.00 | -$9.40M | $0.00 |
| Net Common Stock Issuance | -$520.40M | -$698.20M | -$538.70M | -$266.10M | -$257.90M |
| Cash Dividends Paid | -$464.80M | -$468.10M | -$2.70B | -$3.93B | -$455.00M |
| Net Other Financing Charges | -$2.96B | -$6.93B | $5.35B | $60.72B | $10.61B |
| Ending Cash Balance | $157.38B | $160.26B | $167.43B | $164.08B | $164.08B |
| Net Change in Cash | -$2.88B | -$7.17B | $3.35B | $62.29B | $12.59B |
| Beginning Cash Balance | $160.26B | $167.43B | $164.08B | $101.79B | $151.49B |
| Free Cash Flow | $1.07B | $923.50M | $1.24B | $4.19B | $1.10B |
No comments yet — be the first to weigh in on CME.
Sign in to join the discussion.